M&A Advisor for Urgent Care Business Owners: 2026 Sell-Side Guide

By Christoph Totter, Managing Partner, CT Acquisitions. Last reviewed: July 2026.

An M&A advisor for an urgent care business is a sell-side investment banker or boutique healthcare M&A firm who runs a confidential, competitive process to sell a single-site, small-multi, or regional urgent care platform to strategic operators (Concentra, GoHealth, MedExpress, CityMD) or private equity sponsors backing platform roll-ups. The urgent care sector has been consolidating since 2018, with strategic exits like the VillageMD acquisition of Summit Health and CityMD announced November 7, 2022, at a headline $8.9 billion, and platform investments from TPG Growth (GoHealth Urgent Care), Optum/UnitedHealth Group (MedExpress), and Select Medical (Concentra) shaping the buyer universe. This guide describes what an urgent care M&A advisor does in 2026, how process economics work at lower-middle-market scale, which buyers would likely bid, and how CT Acquisitions positions relative to the specialty healthcare boutiques.

Executive Summary

Urgent care remains an active consolidation vertical in 2026, with strategic acquirers backed by public parents ( Select Medical, NYSE: SEM , and UnitedHealth Group, NYSE: UNH ) and PE-backed platforms such as GoHealth Urgent Care (TPG Growth) and FastMed (ABRY Partners).

• Urgent care remains an active consolidation vertical in 2026, with strategic acquirers backed by public parents (Select Medical, NYSE: SEM, and UnitedHealth Group, NYSE: UNH) and PE-backed platforms such as GoHealth Urgent Care (TPG Growth) and FastMed (ABRY Partners).
• Public data on private LMM multiples is thin. Provident Healthcare Partners, Cain Brothers, and VMG Health publish urgent care sector commentary that anchors expectations at the platform level, not at every operator level.
• The largest disclosed urgent care transaction in the last five years would be VillageMD’s acquisition of Summit Health and CityMD, backed by Walgreens Boots Alliance (NASDAQ: WBA).
• Payor mix, occupational medicine mix, corporate practice of medicine (CPOM) structure, and real estate strategy would be the four biggest EBITDA-quality drivers a buyer scrutinizes, per market commentary published by VMG Health and Provident’s research.
• An LMM sell-side M&A advisor for urgent care would typically run a 5-8 month process with a curated buyer list of 40-80 parties, per Axial’s published LMM process benchmarks.

Key Findings

Urgent care M&A activity has been driven by four public or PE-controlled strategic platforms: GoHealth Urgent Care (TPG Growth) , CityMD (Summit Health, acquired by VillageMD in 2023) , MedExpress (Optum) , and Concentra (Select Medical) . Occupational medicine revenue would command a valuation premium versus pure walk-in acute care, based on Select Medical’s Concentra segment disclosures , which show occupational health as a distinct margin profile. The Corporate Practice.

1. Urgent care M&A activity has been driven by four public or PE-controlled strategic platforms: GoHealth Urgent Care (TPG Growth), CityMD (Summit Health, acquired by VillageMD in 2023), MedExpress (Optum), and Concentra (Select Medical).
2. Occupational medicine revenue would command a valuation premium versus pure walk-in acute care, based on Select Medical’s Concentra segment disclosures, which show occupational health as a distinct margin profile.
3. The Corporate Practice of Medicine (CPOM) doctrine varies by state, and the transaction structure typically uses a Management Services Organization (MSO) plus a Professional Corporation (PC) friendly-physician arrangement. Reference frameworks include the American Bar Association’s overview of CPOM and HHS OIG’s compliance guidance.
4. Volume normalization after the 2020-2022 COVID-19 testing peak would require normalized EBITDA adjustments during quality-of-earnings review. CDC’s National Center for Health Statistics COVID-19 surveillance documents the surge and subsequent normalization.
5. Payor mix (commercial vs Medicare vs Medicaid vs self-pay) drives contribution margin. CMS data and commercial payer contracts would frame the reimbursement environment.
6. Real estate ownership versus lease treatment materially affects the transaction structure. Medical Properties Trust (NYSE: MPW) and Healthcare Realty (NYSE: HR) demonstrate that healthcare real estate is separately tradable.
7. Sell-side fees at LMM scale would typically follow a modified Lehman or double-Lehman structure with a monthly retainer. See CT Acquisitions’ M&A advisor fees 2026 breakdown and fee structure guide.
8. Boutique healthcare M&A specialists active in urgent care include Provident Healthcare Partners, Cain Brothers (a KeyBanc Capital Markets company), and valuation firm VMG Health.
9. Strategic buyer preference would likely lean toward multi-site platforms with contracted occupational medicine revenue, per Select Medical’s public filings describing Concentra’s operating model.
10. Deal certainty at close depends on regulatory review (Hart-Scott-Rodino reporting thresholds, state licensure transfer, DEA registration transfer, and Medicare enrollment reassignment via CMS 855 forms).

What valuation multiples do urgent care businesses sell for by size?

Public data on private urgent care EBITDA multiples at the single-clinic or small-multi level is thin. Sector commentary from Provident Healthcare Partners and VMG Health anchors expectations at the platform level. Reported ranges below reflect market commentary and would not be treated as bids for any specific business. A sell-side advisor would refine these ranges through a competitive process. Size band Structure EBITDA multiple range (indicative) Typical buyer Single site.

Public data on private urgent care EBITDA multiples at the single-clinic or small-multi level is thin. Sector commentary from Provident Healthcare Partners and VMG Health anchors expectations at the platform level. Reported ranges below reflect market commentary and would not be treated as bids for any specific business. A sell-side advisor would refine these ranges through a competitive process.

Size band	Structure	EBITDA multiple range (indicative)	Typical buyer
Single site, <$500K EBITDA	Owner-operator	3.0x – 5.0x SDE (not EBITDA)	Regional operator or physician-buyer
Small multi, 2-5 sites, $500K-$2M EBITDA	MSO/PC structure	5.0x – 7.5x EBITDA (indicative)	PE add-on, regional platform
Regional, 6-15 sites, $2M-$8M EBITDA	MSO/PC + payer contracts	7.5x – 10.0x EBITDA (indicative)	PE platform, strategic
Platform, 15+ sites, $8M+ EBITDA	Institutional infrastructure	10.0x – 14.0x+ EBITDA (indicative)	Growth PE, public strategic

Blending SDE (seller’s discretionary earnings) and EBITDA ranges would be a category error, so this table keeps them separate. Owner-operator single sites typically transact on SDE. Multi-site operators with an institutional MSO layer transact on EBITDA. Reference: Axial’s healthcare services multiple commentary and GF Data’s LMM valuation reports.

What Moves the Urgent Care Multiple

An urgent care M&A advisor would build the confidential information memorandum around the 12 drivers below, ordered by their approximate weight on the multiple realized. The ordering reflects market commentary from Provident Healthcare Partners , VMG Health , and public disclosures from consolidators like Select Medical (NYSE: SEM) . Occupational medicine revenue mix. Occupational health workers’ comp and employer-contracted volume would command a premium versus walk-in acute, per Concentra’s segment.

An urgent care M&A advisor would build the confidential information memorandum around the 12 drivers below, ordered by their approximate weight on the multiple realized. The ordering reflects market commentary from Provident Healthcare Partners, VMG Health, and public disclosures from consolidators like Select Medical (NYSE: SEM).

1. Occupational medicine revenue mix. Occupational health workers’ comp and employer-contracted volume would command a premium versus walk-in acute, per Concentra’s segment reporting under Select Medical.
2. Payor mix and commercial reimbursement contracts. Commercial share above 60 percent would materially expand contribution margin versus a Medicare-heavy book. Reference: CMS statistics.
3. Same-site volume growth (3-5 year trend). Buyers would normalize for COVID testing surge (2020-2022) per CDC surveillance data.
4. Real estate strategy. Owned real estate would allow sale-leaseback structuring with a healthcare REIT like Healthcare Realty (NYSE: HR).
5. Provider mix and physician retention. Employed physician model would price higher than a heavy locum tenens dependency. See provider staffing market data.
6. CPOM structural compliance. Clean MSO/PC structure with defensible economics per ABA Health eSource commentary.
7. EMR and technology stack. Modern EMR (Epic, Athenahealth, Practice Fusion) would reduce integration risk. See Athenahealth.
8. Geographic clustering. Contiguous market density enables shared marketing, staffing, and payer negotiation leverage.
9. Payer contract portability. In-network status with major regional payers (Anthem, UnitedHealthcare, Cigna, Aetna) that survives a change of ownership. Reference: UnitedHealthcare.
10. Ancillary services. Imaging, laboratory, and pharmacy captures margin.
11. Same-store revenue per visit. Revenue per visit versus benchmark data published by Urgent Care Association (UCA).
12. Management team continuity through close and earn-out. Buyers typically require 24-36 month founder rollover or transition consulting.

Who are the active buyers acquiring urgent care businesses?

The urgent care buyer universe in 2026 would be dominated by five named strategic and PE-backed platforms plus a bench of regional PE add-on buyers. Each is verifiable through public filings or company websites.

The urgent care buyer universe in 2026 would be dominated by five named strategic and PE-backed platforms plus a bench of regional PE add-on buyers. Each is verifiable through public filings or company websites.

GoHealth Urgent Care (TPG Growth)

GoHealth Urgent Care operates in partnership with health systems including Northwell Health, Hartford HealthCare, Legacy Health, Novant Health, and Dignity Health. It is backed by TPG Growth, TPG’s middle-market growth platform. GoHealth would be a strategic acquirer for operators with clean health-system-partnership fit.

CityMD (Summit Health, VillageMD/Walgreens)

CityMD, as a subsidiary of Summit Health, was acquired by VillageMD (a Walgreens Boots Alliance company) in a transaction announced November 7, 2022, and completed in January 2023 at a headline value of $8.9 billion, per WBA’s release. CityMD would be a strategic acquirer for northeast urgent care platforms with commercial payor density.

MedExpress (Optum / UnitedHealth Group)

MedExpress operates as part of Optum, the health services arm of UnitedHealth Group (NYSE: UNH). MedExpress would be a strategic acquirer for platforms that fit the Optum Care network strategy.

Concentra (Select Medical)

Concentra is the largest occupational medicine platform in the United States, operating as a segment of Select Medical (NYSE: SEM). Concentra’s segment reporting shows occupational medicine and physical therapy alignment. Concentra would be a strategic acquirer for occupational medicine platforms and hybrid occ-med plus urgent care operators.

FastMed (ABRY Partners)

FastMed operates a multi-state urgent care platform backed by ABRY Partners, a Boston-based private equity firm with a healthcare focus. FastMed would be a PE-backed add-on acquirer for southeast and southwest operators.

Regional PE add-on buyers

Beyond named platforms, specialty PE firms active in physician-services roll-ups (per PitchBook deal databases and disclosed sponsor investments) would participate as financial buyers. This is where a curated advisor buyer list adds value, because most of these sponsors are not publicly indexed against urgent care specifically.

Which M&A advisors specialize in urgent care transactions?

Three specialty healthcare M&A firms publish research on urgent care and would be visible in the vertical. All three are legitimate, credentialed peers of CT Acquisitions in the healthcare M&A market.

Three specialty healthcare M&A firms publish research on urgent care and would be visible in the vertical. All three are legitimate, credentialed peers of CT Acquisitions in the healthcare M&A market.

Provident Healthcare Partners

Provident Healthcare Partners is a Boston-based specialty healthcare investment bank. Provident publishes sector commentary covering urgent care, physician practice management, and outpatient services. Provident would typically compete for platform and upper-middle-market urgent care mandates.

Cain Brothers, a division of KeyBanc Capital Markets

Cain Brothers is a healthcare-focused investment banking division of KeyBanc Capital Markets (part of KeyCorp, NYSE: KEY). Cain Brothers covers large healthcare M&A across services, providers, and payers, including outpatient care platforms.

VMG Health

VMG Health is a Dallas-based healthcare valuation and transaction advisory firm that publishes healthcare sector research, including physician services and urgent care commentary. VMG Health is primarily positioned as a valuation and fair market opinion firm rather than a full sell-side execution bank, though it advises on transactions.

How are Connecticut urgent care acquisitions positioned in 2026?

CT Acquisitions is a lower-middle-market sell-side and buy-side M&A advisor for businesses generally between $1 million and $50 million in enterprise value. In urgent care specifically, CT would fit best on single-site, small-multi (2-5 clinics), and regional (up to 15 clinics) sell-side mandates, where the seller wants a boutique process, curated buyer list, and owner-aligned fee structure. CT is not the largest healthcare M&A firm and does not claim to.

CT Acquisitions is a lower-middle-market sell-side and buy-side M&A advisor for businesses generally between $1 million and $50 million in enterprise value. In urgent care specifically, CT would fit best on single-site, small-multi (2-5 clinics), and regional (up to 15 clinics) sell-side mandates, where the seller wants a boutique process, curated buyer list, and owner-aligned fee structure.

CT is not the largest healthcare M&A firm and does not claim to be. Provident Healthcare Partners, Cain Brothers, and VMG Health each have deeper healthcare-only track records at platform scale. CT’s wedge is at the LMM tier: an owner-aligned fee structure (see CT M&A advisor fees 2026), a curated institutional buyer list of over 100 vetted parties, and a single-partner-per-deal model. CT is positioned as an LMM-focused option, not a claim to be the best or the top firm in urgent care.

How the Sell-Side Process Would Work for Urgent Care

A confidential sell-side process for a $500K to $8M EBITDA urgent care operator would run roughly 5 to 8 months from engagement letter to close, with the following month-by-month cadence. This aligns with LMM benchmarks published by Axial and CT Acquisitions’ investment banking process guide .

A confidential sell-side process for a $500K to $8M EBITDA urgent care operator would run roughly 5 to 8 months from engagement letter to close, with the following month-by-month cadence. This aligns with LMM benchmarks published by Axial and CT Acquisitions’ investment banking process guide.

Month 0-1: Preparation and Quality of Earnings

Sell-side QoE, financial normalization, add-back schedule, provider utilization analysis, and payor-mix analytics. Reference: CT sell-side QoE guide.

Month 1-2: Marketing Materials and Buyer List

Confidential information memorandum (CIM), teaser, curated 40-80 buyer list (mix of strategic and PE), NDA process, initial outreach.

Month 2-4: Initial Bids and Management Meetings

Indications of interest (IOIs), management meetings, site visits, second-round data room access.

Month 4-5: Letter of Intent

Best-and-final bids, letter of intent negotiation (see CT LOI framework), exclusivity period.

Month 5-7: Confirmatory Diligence

Buyer QoE, legal diligence (state licensure, DEA, CPOM structure review), payor contract review, real estate diligence, HR diligence, IT diligence. Reference: CT due diligence checklist.

Month 6-8: Definitive Agreements and Close

Stock purchase agreement or asset purchase agreement negotiation, disclosure schedules, escrow arrangement, working capital peg, closing conditions including regulatory approvals, Medicare 855 reassignments, and state licensure transfer.

What regulatory and structural mechanics affect urgent care M&A in 2026?

Urgent care transactions in 2026 involve at least six regulatory workstreams, each of which an M&A advisor would coordinate with counsel.

Urgent care transactions in 2026 involve at least six regulatory workstreams, each of which an M&A advisor would coordinate with counsel.

Corporate Practice of Medicine (CPOM)

Most states restrict corporate ownership of medical practices. Transactions typically use an MSO/PC structure where the MSO provides administrative services under a management services agreement (MSA) and the PC is owned by a friendly physician. Reference: ABA Health eSource on CPOM.

Medicare Enrollment Transfer

Change of ownership requires CMS 855 form filings to reassign Medicare provider enrollment. Timing risk is real and would extend close by 30-90 days if not managed early.

DEA Registration Transfer

Controlled-substance prescribing (e.g., for pain management dispensing) requires new DEA registration at the new owner entity. Transfer processes vary by state.

State Licensure Transfer

State medical facility licenses (varies by state), pharmacy licenses (where applicable), and lab licenses (CLIA per CMS CLIA program) must be transferred or newly issued.

HSR Antitrust Review

Transactions above the annually adjusted Hart-Scott-Rodino thresholds require pre-merger notification to the FTC and DOJ. Most single-site and small-multi urgent care transactions would fall below thresholds, but platform-scale deals would trigger review.

Anti-Kickback and Stark Compliance

Physician-owned or physician-partnered arrangements require anti-kickback and Stark Law review, per HHS OIG guidance.

How to Choose an M&A Advisor for Your Urgent Care Business

A rigorous advisor selection would evaluate 12 criteria, not just brand-name recognition. The list below is drawn from CT Acquisitions’ published guidance on M&A advisor versus business broker and general LMM sell-side practice. Verifiable healthcare M&A track record (published deal tombstones, disclosed transactions, or references). Understanding of the CPOM/MSO/PC structure specific to your state. Curated buyer list including named strategic acquirers (GoHealth, CityMD, MedExpress, Concentra, FastMed) plus PE add-on buyers.

A rigorous advisor selection would evaluate 12 criteria, not just brand-name recognition. The list below is drawn from CT Acquisitions’ published guidance on M&A advisor versus business broker and general LMM sell-side practice.

1. Verifiable healthcare M&A track record (published deal tombstones, disclosed transactions, or references).
2. Understanding of the CPOM/MSO/PC structure specific to your state.
3. Curated buyer list including named strategic acquirers (GoHealth, CityMD, MedExpress, Concentra, FastMed) plus PE add-on buyers.
4. Fee structure aligned with your size band. See CT fees guide and M&A advisor cost overview.
5. Monthly retainer transparency. See CT retainer guide.
6. Sell-side quality-of-earnings process ownership. See CT sell-side QoE guide.
7. Realistic multiple range grounded in comparable data, not aspirational rounding.
8. Disclosed conflict-of-interest policy (no double-side representation).
9. Single-partner accountability rather than junior-heavy staffing.
10. Owner-aligned success fee (transaction-based, not front-loaded).
11. Willingness to walk away from bids that would disadvantage the owner.
12. Neutral, non-disparaging positioning versus peer firms.

What EBITDA multiples apply by deal size in 2026?

EBITDA multiples for lower middle market businesses vary by size, buyer type, and vertical. The table below shows typical bands for privately-held sellers in 2026 based on GF Data and Axial 2025 benchmarks.

EBITDA size band	Typical multiple	Dominant buyer type
$500K to $1M	3.0x to 4.5x	Individual buyers, ETA, small local PE
$1M to $3M	4.0x to 6.0x	Search funds, small PE, family offices
$3M to $10M	5.5x to 8.0x	Lower middle market PE, strategic tuck-ins
$10M to $25M	7.0x to 10.5x	Middle market PE platforms, strategic acquirers

Frequently Asked Questions

What does an M&A advisor for an urgent care business actually do?

An M&A advisor for an urgent care business runs a confidential, competitive sell-side process to sell your clinic or multi-site platform to strategic operators (Concentra, GoHealth, CityMD, MedExpress) or PE-backed platforms. The advisor prepares the CIM, curates the buyer list, negotiates the LOI, coordinates due diligence, and closes the transaction, per LMM benchmarks published by Axial.

How much does an M&A advisor for urgent care charge?

LMM sell-side M&A advisor fees would typically follow a modified Lehman or double-Lehman success-fee structure plus a monthly retainer. Total fees would range from 3 to 8 percent of transaction value, weighted toward the lower end for larger deals. See CT’s 2026 fees guide and fee structure breakdown.

What multiple would my urgent care clinic sell for?

Public data on private urgent care multiples is thin. Single-site owner-operator clinics would typically transact on SDE (3.0x to 5.0x range indicative), while multi-site operators with an institutional MSO layer would transact on EBITDA (5.0x to 14.0x+ range depending on size and buyer type), per sector commentary from Provident Healthcare Partners.

Who are the biggest urgent care buyers in 2026?

The named strategic buyers would be GoHealth Urgent Care (TPG Growth), CityMD (VillageMD/Walgreens), MedExpress (Optum/UnitedHealth), and Concentra (Select Medical, NYSE: SEM). PE-backed buyers include FastMed (ABRY Partners) plus a bench of specialty physician-services sponsors.

Should I hire a business broker or an M&A advisor for my urgent care?

For single-site owner-operator clinics under $500K SDE, a business broker may be appropriate. For multi-site operators, regional platforms, and any operator with institutional payor contracts, an M&A advisor with healthcare sector experience would typically deliver a materially better outcome. See CT’s advisor vs. broker guide.

Would a strategic buyer or PE buyer pay more?

The answer depends on strategic fit. Strategic buyers like Concentra or GoHealth would pay for occupational medicine density, health-system partnership fit, or geographic infill. PE buyers would pay for platform scale, growth trajectory, and management team quality. See CT’s strategic vs. financial buyer comparison.

How long does an urgent care sell-side process take?

Typically 5 to 8 months from engagement letter to close, per Axial’s LMM benchmarks. Regulatory workstreams (Medicare enrollment reassignment, state licensure transfer, DEA registration transfer, CPOM structure review) can extend timing by 30-90 days.

What kills urgent care deals at LOI?

The most common LOI-to-close breakdowns would be QoE-driven EBITDA reductions, payor contract non-transferability, CPOM structure defects, real estate lease surprises, and physician retention concerns. See CT LOI framework for a risk-mapped approach.

Methodology and Data Sources

This guide draws on public sector commentary from Provident Healthcare Partners , Cain Brothers , and VMG Health ; public filings from Select Medical (NYSE: SEM) , UnitedHealth Group (NYSE: UNH) , and Walgreens Boots Alliance (NASDAQ: WBA) ; disclosed transactions including the VillageMD acquisition of Summit Health and CityMD ; and regulatory sour…

This guide draws on public sector commentary from Provident Healthcare Partners, Cain Brothers, and VMG Health; public filings from Select Medical (NYSE: SEM), UnitedHealth Group (NYSE: UNH), and Walgreens Boots Alliance (NASDAQ: WBA); disclosed transactions including the VillageMD acquisition of Summit Health and CityMD; and regulatory sources including CMS, HHS OIG, FTC, and DEA Diversion Control. LMM process benchmarks reflect published commentary from Axial and GF Data. Sister vertical framing draws on CT Acquisitions’ published pages for dental practice, veterinary practice, and the dermatology M&A multiples 2026 guide.

Multiple ranges are illustrative and would not be treated as bids for any specific business. Blending SDE and EBITDA ranges would be a category error and this report keeps them separate. Named advisor and buyer references reflect public information available as of July 2026 and would be verified against then-current data before any engagement decision.

Disclaimer. This guide is not an appraisal, not investment advice, not legal advice, not tax advice, not financial advice, and not a prediction. Multiples, deal terms, and buyer preferences vary materially by facts and circumstances of each transaction. Owners considering a sale should engage licensed legal, tax, and financial advisors qualified in their jurisdiction. CT Acquisitions is a registered M&A advisor and does not provide legal or tax advice.